Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H OERTEL

Showing results (661-670 of 678) with videos related to

Pageof 68
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2017
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [<sup>123</sup> I]-FP-CIT SPECT imaging: The [<sup>123</sup> I]-FP-CIT study groupHani T S Benamer, Jim Patterson, Donald G Grosset, et al.
Neurology|January 26, 2005
The role of radiotracer imaging in Parkinson diseaseB Ravina, D Eidelberg, J E Ahlskog, et al.
Annals of Clinical and Translational Neurology|December 11, 2014
High prevalence of NMDA receptor IgA/IgM antibodies in different dementia typesSarah Doss, Klaus-Peter Wandinger, Bradley T Hyman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2019
How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsyMax-Joseph Grimm, Gesine Respondek, Maria Stamelou, et al.
The Lancet. Neurology|July 24, 2021
Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorderMitchell G Miglis, Charles H Adler, Elena Antelmi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 14, 2017
Which ante mortem clinical features predict progressive supranuclear palsy pathology?Gesine Respondek, Carolin Kurz, Thomas Arzberger, et al.
The New England Journal of Medicine|February 15, 2013
Neurostimulation for Parkinson's disease with early motor complicationsW M M Schuepbach, J Rau, K Knudsen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2017
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaGünter U Höglinger, Gesine Respondek, Maria Stamelou, et al.
Brain Communications|December 4, 2025
Lack of epistatic interaction of <i>SNCA</i> with <i>APOE</i> in synucleinopathiesPrabhjyot Saini, Eric Yu, Mehrdad A Estiar, et al.
The Lancet. Neurology|October 15, 2017
Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysisBarbara Schormair, Chen Zhao, Steven Bell, et al.
Pageof 68

Showing results (661-670 of 678) with videos related to

Sort By:
Pageof 68
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2017
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [<sup>123</sup> I]-FP-CIT SPECT imaging: The [<sup>123</sup> I]-FP-CIT study groupHani T S Benamer, Jim Patterson, Donald G Grosset, et al.
Neurology|January 26, 2005
The role of radiotracer imaging in Parkinson diseaseB Ravina, D Eidelberg, J E Ahlskog, et al.
Annals of Clinical and Translational Neurology|December 11, 2014
High prevalence of NMDA receptor IgA/IgM antibodies in different dementia typesSarah Doss, Klaus-Peter Wandinger, Bradley T Hyman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2019
How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsyMax-Joseph Grimm, Gesine Respondek, Maria Stamelou, et al.
The Lancet. Neurology|July 24, 2021
Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorderMitchell G Miglis, Charles H Adler, Elena Antelmi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 14, 2017
Which ante mortem clinical features predict progressive supranuclear palsy pathology?Gesine Respondek, Carolin Kurz, Thomas Arzberger, et al.
The New England Journal of Medicine|February 15, 2013
Neurostimulation for Parkinson's disease with early motor complicationsW M M Schuepbach, J Rau, K Knudsen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2017
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaGünter U Höglinger, Gesine Respondek, Maria Stamelou, et al.
Brain Communications|December 4, 2025
Lack of epistatic interaction of <i>SNCA</i> with <i>APOE</i> in synucleinopathiesPrabhjyot Saini, Eric Yu, Mehrdad A Estiar, et al.
The Lancet. Neurology|October 15, 2017
Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysisBarbara Schormair, Chen Zhao, Steven Bell, et al.
Pageof 68